Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
about
Drug-eluting fibers for HIV-1 inhibition and contraceptionUser preferences in a carrageenan-based vaginal drug delivery systemNew Biomedical Technologies and Strategies for Prevention of HIV and Other Sexually Transmitted InfectionsPolyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infectionAnalysis of vaginal microbicide film hydration kinetics by quantitative imaging refractometryFormulation, pharmacokinetics and pharmacodynamics of topical microbicides.The importance of the vaginal delivery route for antiretrovirals in HIV prevention.Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.The role of lactobacilli and probiotics in maintaining vaginal health.Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities.Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery.Clinical evaluation of microbicide formulationsEvaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 Prevention.Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.Microbicides for the Treatment of Sexually Transmitted HIV Infections.In search of the optimal delivery method for anti-HIV microbicides: are intravaginal rings the way forward?Formulation, development and characterization of mucoadhesive film for treatment of vaginal candidiasisEngineering and characterization of simplified vaginal and seminal fluid simulants.Effects of processing and storage on Pediococcus pentosaceus SB83 in vaginal formulations: lyophilized powder and tabletsMicrobicides: still a long road to successSpray drying tenofovir loaded mucoadhesive and pH-sensitive microspheres intended for HIV prevention.Development of a vaginal delivery film containing EFdA, a novel anti-HIV nucleoside reverse transcriptase inhibitor.Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.Specific microbicides in the prevention of HIV infection.Current and future microbicide approaches aimed at preventing HIV infection in women.Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.An overview of antiretroviral pre-exposure prophylaxis of HIV infection.Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.Vaginal suppositories containing Lactobacillus acidophilus: development and characterization.On-demand microbicide products: design matters.Vaginal drug delivery for the localised treatment of cervical cancer.Time-resolved imaging refractometry of microbicidal films using quantitative phase microscopy.Pediococcus pentosaceus SB83 as a potential probiotic incorporated in a liquid system for vaginal delivery.Development of poloxamer gel formulations via hot-melt extrusion technology.Vaginal film for prevention of HIV: using visual and tactile evaluations among potential users to inform product design.Dynamic mechanical behaviour of nanoparticle loaded biodegradable PVA films for vaginal drug delivery.Vaginal Mucosa and Drug Delivery
P2860
Q21133885-111DE14D-4062-4018-A727-073DF40056E6Q27318051-A7498171-F530-42D2-A2DA-6A531F91D634Q28072213-F98EE435-2ACB-4BAF-826A-D68D9EC8C3E7Q28489042-60F89B32-6B11-45EF-9B80-29EBCFB794D4Q28537930-BABE4836-4CBA-4EE4-9015-8CCC481FDC1AQ30412592-E4365DB3-3AA6-4788-A388-35045E0A8400Q30414890-79ABAB3F-79ED-4629-8511-B7612D8A0048Q33821090-B5D0E89E-AB44-4612-AB82-7DADA08D3174Q34381043-4AE27EAB-4B4A-450D-80D7-962FD5858712Q34548621-75744AEE-31A4-4783-903D-3EB8FE49A666Q34604290-6E4D551C-3F5F-4D23-8297-7DE77EF1ECBBQ34645034-D482127C-6C53-4F19-8C52-D5D94AC64D4EQ34785687-40924493-0059-45E6-B2B0-DA979595621EQ35861276-7369C235-71C1-4E61-A962-AC5872527510Q36112191-F4E6740F-B162-451E-9EF6-413137ABCBEBQ36630547-FD1D816F-0C02-455A-9DFB-18F53633C687Q36675664-02EF2FBC-AAC6-4D79-A85C-7105584E4D1AQ36890847-23BC6895-A616-4D55-85EE-DD5F38B1330CQ36988564-76CB85CB-3B0B-4ADC-8DF2-E485A2548361Q37130757-41C03B8A-FE7D-4F8B-84E9-4E2024B1DE5AQ37157173-75E6BBFF-A9F9-493A-8D9C-F2CB8D36BF1DQ37687006-EAAA5A9C-89F9-4307-B4F0-1F97B8153CCCQ37834095-B82BB73A-8FE0-4705-95BD-4EB686AA18BEQ37932048-CFDF5594-8B46-4AD5-BFC6-A40185836EFBQ37984498-7E13D5EA-C4C1-4084-BE90-8D41937CFFDBQ37990037-9A305541-6F44-493F-AC8C-1EB86A045A13Q38196410-50A49BD0-D3CF-45F2-8720-F4AFC4561F70Q38222809-3CDCC126-7393-44C2-B25E-27587D98EEDFQ38260862-1D43025E-6D86-4525-8205-580CD56DE07FQ38952328-E9099FF5-98FE-40EA-865F-9E204AA1EBE3Q39356290-9CE8133E-8316-4180-88C5-9A1DAABCF487Q39361267-59818EAE-013B-4BB3-B3D0-1B50D9B8F94FQ43050393-B2987C2D-FEF4-4FE2-AC22-0CF7CB3BF3CCQ44772007-5C6E08DC-0462-48EC-ABBA-C28F3BA752E3Q47239089-C4A39A71-97C7-4DDB-91C0-25AA4ECA2F58Q47834269-A1111285-31C8-4271-8D12-761B1BD45F5EQ48361538-086FD890-EA93-4F53-9C97-1644C3683466Q57570821-7252AC69-CDBF-418E-85C5-780241EDC19C
P2860
Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in development, scale ...... cide gels, films, and tablets.
@en
Advances in development, scale ...... cide gels, films, and tablets.
@nl
type
label
Advances in development, scale ...... cide gels, films, and tablets.
@en
Advances in development, scale ...... cide gels, films, and tablets.
@nl
prefLabel
Advances in development, scale ...... cide gels, films, and tablets.
@en
Advances in development, scale ...... cide gels, films, and tablets.
@nl
P2093
P1433
P1476
Advances in development, scale ...... cide gels, films, and tablets.
@en
P2093
David Goldman
David R Friend
Lisa C Rohan
Markus Krumme
Stuart Smoot
P304
P356
10.1016/J.ANTIVIRAL.2010.09.010
P478
88 Suppl 1
P50
P577
2010-12-01T00:00:00Z